• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于单克隆抗体的血浆纤维蛋白降解产物酶免疫测定法。

A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.

作者信息

Koppert P W, Hoegee-de Nobel E, Nieuwenhuizen W

机构信息

Gaubius Institute TNO, Leiden, The Netherlands.

出版信息

Thromb Haemost. 1988 Apr 8;59(2):310-5.

PMID:3133813
Abstract

We have developed a sandwich-type enzyme immunoassay (EIA) for the quantitation of fibrin degradation products (FbDP) in plasma with a time-to-result of only 45 minutes. The assay is based on the combination of the specificities of two monoclonal antibodies (FDP-14 and DD-13), developed in our institute. FDP-14, the capture antibody, binds both fibrinogen degradation products (FbgDP) and FbDP, but does not react with the parent fibrin(ogen) molecules. It has its epitope in the E-domain of the fibrinogen molecule on the B beta-chain between amino acids 54-118. Antibody DD-13 was raised using D-dimer as antigen and is used as a tagging antibody, conjugated with horse-radish peroxidase. A strong positive reaction is obtained with a whole blood clot lysate (lysis induced by tissue-type plasminogen activator) which is used as a standard. The EIA does virtually not detect FbgDP i.e. purified fragments X, Y, or FbgDP generated in vitro in plasma by streptokinase treatment. This indicates that the assay is specific for fibrin degradation products. We have successfully applied this assay to the plasma of patients with a variety of diseased states. In combination with the assay previously developed by us for FbgDP and for the total amount of FbgDP + FbDP (TDP) in plasma, we are now able to study the composition of TDP in patients plasma in terms of FbgDP and FbDP.

摘要

我们开发了一种夹心型酶免疫测定法(EIA),用于定量血浆中的纤维蛋白降解产物(FbDP),出结果时间仅为45分钟。该测定法基于我们研究所开发的两种单克隆抗体(FDP - 14和DD - 13)的特异性组合。捕获抗体FDP - 14可结合纤维蛋白原降解产物(FbgDP)和FbDP,但不与纤维蛋白原分子反应。它的表位位于Bβ链上纤维蛋白原分子E结构域中氨基酸54 - 118之间。以D - 二聚体为抗原制备的抗体DD - 13用作标记抗体,与辣根过氧化物酶结合。以全血凝块裂解物(由组织型纤溶酶原激活剂诱导裂解)作为标准品可获得强阳性反应。该EIA实际上检测不到FbgDP,即体外经链激酶处理血浆产生的纯化片段X、Y或FbgDP。这表明该测定法对纤维蛋白降解产物具有特异性。我们已成功将该测定法应用于患有各种疾病状态患者的血浆。结合我们之前开发的用于血浆中FbgDP以及FbgDP + FbDP总量(TDP)的测定法,我们现在能够从FbgDP和FbDP的角度研究患者血浆中TDP的组成。

相似文献

1
A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.一种基于单克隆抗体的血浆纤维蛋白降解产物酶免疫测定法。
Thromb Haemost. 1988 Apr 8;59(2):310-5.
2
A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.血浆中原发性纤维蛋白溶解产物的定量酶免疫测定法。
Thromb Haemost. 1987 Feb 3;57(1):25-8.
3
New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.使用单克隆抗体对血浆中纤维蛋白-纤维蛋白原降解产物进行新型酶免疫测定。
J Lab Clin Med. 1987 Jan;109(1):75-84.
4
[A specific marker of thrombolysis: DDE complex].[溶栓的一种特异性标志物:D - 二聚体复合物]
C R Acad Sci III. 1987;304(11):307-11.
5
Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.交联纤维蛋白降解产物的检测——一种使用单克隆抗体的免疫测定法。
Thromb Haemost. 1983 Aug 30;50(2):591-4.
6
A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentrations.一种基于单克隆抗体的定量酶免疫测定法,用于测定血浆纤维蛋白原浓度。
Thromb Haemost. 1988 Dec 22;60(3):415-8.
7
Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.通过纤维蛋白特异性抗体在弥散性血管内凝血患者血浆中检测到的纤维蛋白主要由高分子量因子XIIIa交联和纤溶酶修饰的复合物组成,这些复合物部分含有纤维蛋白肽A。
Thromb Haemost. 1997 Sep;78(3):1069-78.
8
[Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
Rinsho Byori. 1991 Jul;39(7):753-7.
9
Validation, calibration, and specificity of quantitative D-dimer assays.定量D-二聚体检测的验证、校准及特异性
Semin Vasc Med. 2005 Nov;5(4):315-20. doi: 10.1055/s-2005-922476.
10
Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.交联纤维蛋白降解产物的酶联免疫吸附测定作为凝块溶解指标的有效性。
Circulation. 1990 Oct;82(4):1159-68. doi: 10.1161/01.cir.82.4.1159.

引用本文的文献

1
Specific effects of fibrinogen and the γA and γ'-chain fibrinogen variants on angiogenesis and wound healing.纤维蛋白原以及γA和γ'-链纤维蛋白原变体对血管生成和伤口愈合的特定作用。
Tissue Eng Part A. 2015 Jan;21(1-2):106-14. doi: 10.1089/ten.TEA.2014.0020. Epub 2014 Aug 5.
2
Hyperfibrinolysis in hepatosplenic schistosomiasis.肝脾型血吸虫病中的高纤维蛋白溶解现象。
J Clin Pathol. 1996 Dec;49(12):990-3. doi: 10.1136/jcp.49.12.990.
3
Increased prothrombin fragment 1 + 2 and D-dimer in first-degree relatives of type 2 diabetic patients. Prethrombotic state in relatives of type 2 diabetic patients.
2型糖尿病患者一级亲属中凝血酶原片段1+2和D-二聚体升高。2型糖尿病患者亲属的血栓前状态。
Acta Diabetol. 1996 Jul;33(2):118-21. doi: 10.1007/BF00569421.
4
New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.利用单克隆抗体测定纤维蛋白和纤维蛋白(原)衍生物的新策略。
Blut. 1988 Nov;57(5):285-91. doi: 10.1007/BF00320354.
5
Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation.组织型纤溶酶原激活剂相关纤维蛋白溶解的全身效应及其与原位肝移植中凝血酶生成的关系
Transplantation. 1989 Jun;47(6):978-84. doi: 10.1097/00007890-198906000-00012.
6
Segmentally enclosed thrombolysis in percutaneous transluminal angioplasty for femoropopliteal occlusions: a report from a pilot study.经皮腔内血管成形术治疗股腘动脉闭塞症的节段性封闭溶栓:一项初步研究报告
Cardiovasc Intervent Radiol. 1991 Sep-Oct;14(5):293-8. doi: 10.1007/BF02578453.
7
Changes in the fibrinolytic system associated with physical conditioning.
Eur J Appl Physiol Occup Physiol. 1992;65(5):388-93. doi: 10.1007/BF00243502.